Stephen Hahn said coronavirus testing will be necessary beyond May and 'into the fall,' as he acknowledged the U.S. is 'very close to the peak' of active cases.
The head of the Food and Drug Administration said coronavirus testing will be necessary beyond May and"into the fall," as he acknowledged Sunday morning the U.S. is"very close to the peak" of active cases.
FDA Commissioner Stephen Hahn responded to criticism over why the U.S. is still so"far behind" other countries in terms of COVID-19 testing and potential treatments, telling ABC News that antibody tests and all other determinations made by the agency depends purely on"the data and the science.
"The models do show that we are very close to the peak. So I think that information is accurate," Hahn toldMartha Raddatz Sunday, commending the work of White House Coronavirus Task Force members Dr. Anthony Fauci and Dr. Deborah Birx."This has been a really fast-moving outbreak, so we really have to take this day by day."FDA Commissioner Stephen Hahn:"Further ramping up testing...
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US close to coronavirus peak, but we have to take it 'day by day': FDA commissionerFederal projections suggest relaxing social distancing guidelines at the end of April will lead to a spike in infections. “We’re seeing the impact now of social distancing in the data and it seems to be working,” NateSilver538 says.
Read more »
U.S. still falling short on accurate testing, FDA chief saysDr. Stephen Hahn says more tests are needed and that antibody tests need “to be valid and accurate and reliable.”
Read more »
FDA warns Alex Jones to stop pitching bogus virus remediesU.S. health officials are warning conspiracy theorist and radio host Alex Jones to stop pitching bogus remedies for the coronavirus. The Food and Drug Administration sent a warning letter Thursday ordering Jones to stop falsely claiming that toothpaste, mouth wash and other products sponsored by his
Read more »
FDA grants approval of AstraZeneca's KoselugoThe U.S. Food and Drug Administration on Friday approved Koselugo, or selumetinib, to treat certain pediatric patients with neurofibromatosis type 1. The approval was given to AstraZeneca Pharmaceuticals LP. The FDA said neurofibromatosis type 1 is a genetic disorder of the nervous system that can cause tumors to grow on nerves, adding it is a "debilitating, progressive and often disfiguring rare disease that typically begins early in life.
Read more »
US close to coronavirus peak, but we have to take it 'day by day': FDA commissionerFederal projections suggest relaxing social distancing guidelines at the end of April will lead to a spike in infections. “We’re seeing the impact now of social distancing in the data and it seems to be working,” NateSilver538 says.
Read more »